Articles > Insulins & Non-insulins

Two Minnesota Insurers Move to Cap or Eliminate Out-of-Pocket Insulin Costs

Blue Cross Blue Shield of Minnesota will eliminate out-of-pocket costs for its fully insured customers, while UCare will cap the costs at $25 a month.

Asthma Medication Shown to Slow Early Stages of Diabetic Retinopathy in Mice

Researchers recently published promising results from a mouse study on the use of an asthma drug to inhibit the early stages of retinopathy.

Medica rolls out the program for many of its Minnesota-based customers. It joins Cigna in offering this option in its insurance plans.

However, insulin may be excluded from one of the two proposed methods for drug importation.

FDA Approves Nasally Administered Glucagon to Treat Severe Hypoglycemia

Lilly will market the novel glucagon treatment under the brand name of Baqsimi. It should be available in U.S. pharmacies in the next month.

The Senate’s Insulin Price Reduction Act: What You Need to Know

An overview of the key provisions to this bipartisan bill, and the possible hurdles to its passage.

Jada Louis Died Because She Had to Choose Between Paying for Rent or Insulin

A young woman from Virginia dies from insulin rationing. Read her story and share the resources we provide to help others avoid who might be in the same situation.

Sanofi Negotiating with Biocorp to Integrate Mallya Smart Cap to its Care Platform

Sanofi’s $4 million investment comes shortly after news that Biocorp has gained European approval for its smart cap as a new class of medical device.

Senator Bernie Sanders to Accompany Insulin Caravan to Canada

This marks the first time that a presidential candidate has pledged to take part in direct diabetes activism.

Trump Administration Drops Proposal Banning Drug Rebates for Medicare

It is the second setback against the administration’s efforts to bring down the high price of prescription drugs in the United States.